Beruflich Dokumente
Kultur Dokumente
INTRODUCTION
Objective:
The objective to introduce Eliqui-DX (Apixaban)for better and effective treatment of clotting of blood.
Apixaban:
Apixaban (trade name Eliqui) is an anticoagulant for the prevention of venous thromboembolism and venousthramboembolic events. It is a direct factorXainihibitor.Apixaban has been available in Europe since May 2011 and was approved for preventing venous thromboembolism after elective hip or knee replacement. The FDA approved apixaban in December 2012 with an indication of reducing the risk of stroke and dangerous blood clots (systemic embolism) in patients with atrial fibrillation that is not caused by a heart valve problem.
Apixaban:
yl)phenyl]-4,5-dihydropyrazolo[5,4-c]pyridine-3carboxamide
Chemical data
Formula Mol. Mass C25H25N5O4 459.497 g/mol
Pharmacokinetic data Bioavailability Half-life Excretion ca. 50% 914 h 75% biliary, 25%renally
Mechanism of Action:
Apixaban is an oral, reversible, and selective active site inhibitor of FXa. It does not require anti thrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound FXa, and prothrombinase activity. Apixaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, apixaban decreases thrombin generation and thrombus development.
Pharmacodynamics:
As a result of FXa inhibition, apixaban prolongs clotting tests such as prothrombin time (PT), INR, and activated partial thromboplastic time (aPTT). Changes observed in these clotting tests at the expected therapeutic dose,
however, are small, subject to a high degree of variability, and not useful in monitoring the anticoagulation effect of apixaban. The RotachromHeparin chromogenic assay was used to measure the effect of apixaban on FXa activity in humans during the apixaban development program.
CHAPTER 2
CHAPTER 2
MARKETING STRATEGY
Marketing strategy is a process that can allow an organization to concentrate its resources on the optimal opportunities with the goals of increasing sales and achieving a sustainable competitive advantage. Competitive advantages:
Marketing strategy includes all basic and long-term activities in the field of marketing that deal with the analysis of the strategic initial situation of a company and the formulation, evaluation and selection of market-oriented strategies and therefore contributes to the goals of the company and its marketing objectives.
to monitor progress and a set of contingencies if problems arise in the implementation of the plan. Marketing Mix Modeling is often used to help determine the optimal marketing budget and how to allocate across the marketing mix to achieve these strategic goals. Moreover, such models can help allocate spend across a portfolio of brands and manage brands to create value.
Types of strategies
Marketing strategies may differ depending on the unique situation of the individual business. However there are a number of ways of categorizing some generic strategies. A brief description of the most common categorizing schemes is presented below: Strategies based on market dominance - In this scheme, firms are classified based on their market share or dominance of an industry. Typically there are four types of market dominance strategies:
TYPES OF MARKETING:
Online marketing Direct marketing Newspaper marketing Radio marketing Television marketing
Marketing is the process of communicating the value of a product or service to customers. Marketing might sometimes be interpreted as the art of selling products, but sales is only one part of marketing. As the term "Marketing" may replace "Advertising" it is the overall strategy and function of promoting a product or service to the customer.
Importance of Marketing:
The heart of your business success lies in its marketing. Most aspects of your business depend on successful marketing. The overall marketing umbrella
covers advertising, public relations,promotions.It is the process of introducing and promoting the product or service into the market and encourages sales from the buying public. Sales refer to the act of buying e actual transaction of customers purchasing the product or service.
Marketing generates awareness. Word-of-mouth advertising can be extremely important when developing a publicity campaign. Recent surveys suggest that 90 percent of consumers trust word-of-mouth suggestions.
88 percent of people are likely to pass information about services and products to friends, and 87 percent will pass information to family. These numbers speak to the effectiveness of word-of-mouth campaigns. When people believe in a product or service they will promote and support that product or service.
Marketing a service through radio and television allows consumers to visualize scenarios which seem more real and applicable to their lives.
Marketing creates brand awareness. If marketed effectively, 1-800-FIRE-LINE can become synonymous with volunteering in the emergency services. Marketing will also increase awareness of your organization, and departments will realize your organizations commitment to retention and recruitment efforts in your state.
Advantages of Marketing:
identifies needs and wants of consumers determines demand for product aids in design of products that fulfill consumers needs outlines measures for generating the cash for daily operation, to repay debts and to turn a profit.
identifies competitors and analyzes your product's or firm's competitive advantage identifies new product areas identifies new and/or potential customers
Marketing Disadvantages:
identifies weaknesses in your business skills leads to faulty marketing decisions based on improperly analyzed data creates unrealistic financial projections if information is interpreted incorrectly identifies weaknesses in your overall business plan
10
LABEL OF ELIQUI-DX
Eliqui-DX
2.5 mg
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.
MRP.20.00only Store at room temperature and Protect from light Mfg.by Life care Labs ltd. Lucknow (U.P.) INDIA
11
PACKAGING
12
CHAPTER 3
13
CHAPTER 3
Steps of Promotion:
2. Fax detailing
Detail information of product is faxed to doctors.
4.Publication of a newsletter
Newsletter published consisting information about prevention and treatment of Clotting of blood cause by different agents indirectly promotes the drug.
5. Advertisement
It is also effective means of promotion. Advertisement in journals. Advertisement in scientific magazines
6. Sampling
Provide free trial of product. Free samples are provided to doctors and in hospitals.
7. Personal selling
Sales representative persuade the physicians to prescribe our medicine Eliqui-DX.
14
8. E-detailing
E-detailing to healthcare professionals are very effective as part of an overall multi-channel marketing campaign. Because healthcare providers have opted-in messages are well received. In addition the e- detailing channel provides the following benefits: Ease of Use Speed and Reach Flexibility Fast turn-around times Customization and vivid use of logos and graphics Detailed Tracking of Open Rates and Actions Taken Quick Reply and Follow-Up
9. Tele-detailing
Tele-detailing on its own will work for some physicians, but not all physicians. The same can be said for face-to-face meetings and other forms of communication. The best approach for optimal reach and frequency is to develop a communication strategy that leverages the key benefits of each channel. Healthcare providers have preferences for how they receive pharmaceutical promotional messages. Some prefer phone calls, while others prefer a sales representative, and still others prefer an email or fax.
15
anticoagulants. This medicine helps to prevent blood clots from forming by blocking Factor Xa, which is an
seizures (e.g. phenytoin, etc.) -St Johns Wort (a herbal supplement used for depression -medicines to treat tuberculosis Or other infections (e.g. rifampicin) Taking ELIQUI-DX with food and drink ELIQUI-DX can be taken with or without food.Pregnancy and breast-
important component of blood clotting. After an operation to the hip or knee you may be at a higher risk of developing blood clots in your leg veins. This can cause the legs to swell, with or without pain. If a blood clot travels from your leg to your lungs, it can block blood flow causing breathlessness, with or without chest pain. This condition (pulmonary embolism) can be life-threatening and requires immediate medical
reduction),your doctor will tell you to take ELIQUI-DX 5 hours or more after catheter removal. Children is children and not and
feeding:Ask your doctor or pharmacist for advice before taking any medicine. The effects of ELIQUI-DX on
adolescentsELIQUI-Dx recommended in
pregnancy and the unborn child are not known. You should not take ELIQUIDX if you are pregnant.
16
Contact your doctor immediately if you become pregnant while aking ELIQUIDX. It is not known if ELIQUI-DX passes into human breast milk. Ask your doctor or pharmacist for advice before taking this medicine while breastfeeding. They will advise you to either stop breast-feeding or to stop/not start taking ELIQUI-DX. Driving and using machines ELIQUI-DX has not been shown to impair your ability to drive or use machines. Important information about some of the ingredients of ELIQUI-DX The tablet contains lactose (a type of sugar). If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine. 3. HOW TO TAKE ELIQUI-DX Always take ELIQUI-DX exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure. Dose: The usual dose is one tablet twice a day, for example, one in the morning and one in the evening. Try to take the tablets at the same times every day to help you to remember to take them. You should take the first tablet 12 to 24 hours after your operation. Swallow the tablet with a drink of water. You should take one tablet twice a day, every day, for as long as your doctor tells you to take this prescription. Duration of treatment you have had a major Hip if
you will usually take the tablets for 32 to38 days. If you have had a major knee operation you will usually take the tablets for 10 to 14 days. If you take more ELIQUI-DX than you should: Tell your doctor immediately if you have taken more than the prescribed dose of ELIQUI-DX. Take the medicine pack with you, even if there are no tablets left. If you take more ELIQUIDX than recommended, you may have an increased risk of bleeding. Ifbleeding occurs, surgery or blood transfusions may be required. If you forget to take ELIQUI-DX Take the tablet as soon as you remember and: take the next tablet of ELIQUI-DX at the usual time then continue as normal. If you are not sure what to do or have missed more than one dose, ask your doctor or pharmacist. If you stop taking ELIQUI-DX .Do not stop taking ELIQUI-DX with out
could possibly lead to anaemia, (a low blood cell count which may cause tiredness or paleness). Frequencies are defined as follows: -very common: affects more than 1 user in 10 -common: affects 1 to 10 users in 100 -uncommon: affects 1 to 10 users in 1,000 -rare: affects 1 to 10 users in 10,000 - very rare: affects less than 1 user in 10,000 Common side effects: - Anaemia which may cause tiredness or paleness - Bleeding including: - blood in the urine (that stains the urine pink or red) - bruising and swelling - vaginal bleeding - Nausea (feeling sick) Uncommon side effects: - Reduced number of platelets in your blood (which can affect clotting) - Bleeding including: - bleeding occurring after your operation including bruising and swelling, blood or liquid leaking from the surgical
talking to your doctor first, because the risk of developing a blood clot could be higher if you stop treatment too early. If you have any further questions on the use of this medicine, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS Like all medicines, ELIQUI-DX can cause side effects, although not
wound/incision (wound secretion) - bleeding in your stomach, or blood in the stools - blood found in the urine on laboratory testing ,- bleeding from your nose. - Low blood pressure which may make you feel faint or have a quickened heartbeat. . Manufactured by Life care Pvt ltd, Lucknow and also Contact bowel
everybody gets them. ELIQUI-DX may cause bleedings which may potentially be life threatening. Thebleedings may not be obvious and
no.8957913050.
operation
17
Visual aid
INDICATIONS
It contains apixaban which prevents blood coagulation. Do not take Eliqui-DX if have bleeding disorders. In various thramboembolic events.
18
Apixaban
is an oral, reversible, and selective active site inhibitor of FXa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clotbound FXa, and prothrombinase activity. Apixaban has no direct effect on platelet aggregation, but indirectly inhibits platelet aggregation induced by thrombin. By inhibiting FXa, apixaban decreases thrombin generation and thrombus development
19
CHAPTER 4
20
CHAPTR 4
CONCLUSION
E-detailing of ELIQUI-DX provides all information regarding the drug so that physician considers ELIQUI-DX for prescription for patients that leads to increase of sales of ELIQUI-DX.
Visual aids of ELIQUI-DX is used to illustrate benefits of drug and superiority over other brands so that the prescriber will influenced by visual aids of ELIQUI-DX and will start prescribing the ELIQUI-DX that will increase the sales of ELIQUI-DX.
Advertisement in journals and scientific magazines influences the physicians that will lead to increase sales of ELIQUI-DX.Personal selling through medical representative, he describes all features of ELIQUI-DX and convince the doctors to prescribe so that sales of ELIQUI-DX will increase.
May be because of reminders, such as calender and paper weight which are given to prescriber to remind ELIQUI-DX for prescription so the sales of ELIQUI-DX will increase.
Free samples may increase the sales of product by providing free trial of product. Sponsoring a seminar among doctors regarding the efficacy and use of ELIQUI-DX. That will influence prescribing habit of doctors, promoting the sales of ELIQUI-DX.
These promotional strategies may be adopted by company for boosting the sales of ELIQUI-DX.
21
BIBLIOGRAPHY
Hardman, J.G. ; Gilman, A.G. , Goodman& Gilmans The Pharmacological Basis of Theraputics ; 10th Ed.; McGraw Hill Medicinal Publishing House, New Delhi; 2001; Page no. 1019-1056 Kotler, P.; Keller, K.L.; & Koshy, A. , Marketing Management ; 12 Pearson Prentice Hall ; 2007 ; Page no. 521-540 Smith, M.C., Principals of Pharmaceutical Marketing ; 3rd Ed; CBS Publishers & Distribution, New Delhi; 2002; Page no. 272-300. http:// www.Wikipedia. Com./103.24/ Eliquis http:// www.Medindia.net/brandname/price/ELIQUIS.
th
Ed ;
22